Thermo Fisher announces new suite of assays

By The Science Advisory Board staff writers

July 19, 2021 -- Thermo Fisher Scientific announced a new suite of Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant clones of T cells and B cells.

The company said the assays target multiple parts of the B- and T-cell immune receptors using a single reaction with ultrahigh sensitivity, increasing the probability of malignant clone detection and decreasing the time to results.

The suite is available on Thermo Fisher's Ion GeneStudio S5 system and features integrated analysis and data visualization tools for laboratories and healthcare professionals.

Thermo Fisher opens cGMP plasmid DNA manufacturing facility in Calif.
Thermo Fisher Scientific announced it has officially opened its new current good manufacturing practice (cGMP) plasmid DNA manufacturing facility in Carlsbad,...
Thermo Fisher seeks immuno-oncology research grant proposals
Thermo Fisher Scientific is accepting clinical research project submissions in immuno-oncology for its Oncomine Clinical Research Grant program.
Thermo Fisher Scientific upgrades Quick to Clinic
Thermo Fisher Scientific is showcasing a new version of its Quick to Clinic service for biologic drug developers at the BIO Digital 2021 conference, which...
Thermo Fisher inks U.K. agreement to develop advanced workflows
Thermo Fisher Scientific has signed an agreement with the U.K.'s University of Sheffield to develop advanced workflows for characterizing and monitoring...
Thermo, Moderna ink COVID-19 vaccine manufacturing deal
Moderna has signed a deal with Thermo Fisher Scientific to provide manufacturing services and supply packaging for its COVID-19 vaccine.

Copyright © 2021 scienceboard.net


Conferences
CPhI North America
August 10-12
Philadelphia, Pennsylvania United States
Bioprocessing Summit
August 16-19
Boston, Massachusetts United States
6th Annual CAR-TCR Summit
August 30 - September 2
Online
European Congress of Immunology (ECI) 2021
September 1-4
Belgrade Serbia
Medical Affairs Strategic Summit (MASS)
September 13-15
New Brunswick, New Jersey United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter